JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 477,000 shares, an increase of 16.7% from the November 15th total of 408,600 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

JCR Pharmaceuticals Price Performance

OTCMKTS JCRRF opened at $4.57 on Tuesday. The stock has a 50-day moving average of $4.57 and a two-hundred day moving average of $4.69. JCR Pharmaceuticals has a 1-year low of $4.30 and a 1-year high of $4.70.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.